EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.13.11.38 | Nocardioides sp. | - |
recombinant | - |
1.13.11.38 | Nocardioides sp. KP7 | - |
recombinant | - |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.13.11.38 | - |
Nocardioides sp. |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
1.13.11.38 | 1567 | - |
- |
Nocardioides sp. |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.13.11.38 | 1-hydroxy-2-naphthoate + O2 | - |
Nocardioides sp. | (3E)-4-(2-carboxyphenyl)-2-oxobut-3-enoate | i.e. trans-2'-carboxybenzalpyruvate. The structure of the ring cleavage product is determined upon separation by high-performance liquid chromatography at pH 2.5 by using nuclear magnetic resonance and mass spectroscopic techniques | ? | |
1.13.11.38 | 1-hydroxy-2-naphthoate + O2 | - |
Nocardioides sp. KP7 | (3E)-4-(2-carboxyphenyl)-2-oxobut-3-enoate | i.e. trans-2'-carboxybenzalpyruvate. The structure of the ring cleavage product is determined upon separation by high-performance liquid chromatography at pH 2.5 by using nuclear magnetic resonance and mass spectroscopic techniques | ? |